If you have been harmed by Benicar (olmesartan medoxomil), you may be eligible to receive part of the $300 million that Daiichi Sankyo Inc. and Forest Laboratories Inc. have already agreed to pay to settle claims, but you must act quickly. According to the terms of the settlement, you must have a retainer agreement with a Benicar attorney by 11:59pm EST, in order to take part. Please, do not wait until the last minute to talk to an experienced defective drug attorney and take advantage of this unique opportunity.
On August 1, 2017, Benicar makers announced that they had agreed to pay $300 million to settle both filed and unfiled claims against them. They say that the settlement is not an admission of liability. Those who wish to participate have a very limited amount of time to take action.
Benicar Gastrointestinal Harm
Benicar is used to treat high blood pressure. It has been linked to a gastrointestinal condition called sprue-like enteropathy, which can cause life-threatening malnutrition and permanent injuries. Sprue-like enteropathy is often misdiagnosed as Celiac disease. Symptoms include:
- Nausea and vomiting
- Abdominal pain
- Chronic diarrhea
- Severe weight loss
- Severe malnutrition
If you have been harmed by Benicar, please talk to an experienced defective medical device attorney right away to learn more about your rights and potential compensation. You must retain a Benicar attorney by August 23, 2017 to participate in the current settlement. Please, do not wait until it is too late.